Spectrum Pharmaceuticals, Inc. (SPPI) Misses Q4 EPS by 7c, Sales Fall Inline
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Price: $1.03 --0%
Financial Fact:
Income (loss) from operations: -16M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income (loss) from operations: -16M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) reported Q4 non-GAAP EPS of $0.24, $0.07 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $5.98 million versus the consensus estimate of $52.73 million.
For earnings history and earnings-related data on Spectrum Pharmaceuticals, Inc. (SPPI) click here.
For earnings history and earnings-related data on Spectrum Pharmaceuticals, Inc. (SPPI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- Exclusive: BitGo says institutional conversations are shifting to tokenization
- Benchmark Reiterates Buy Rating on Jumia Technologies (JMIA)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
